Search results
Here's Why You Should Invest in Beam Therapeutics (BEAM) Now
Zacks via Yahoo Singapore Finance· 6 days agoBeam Therapeutics Inc. BEAM is evaluating its leading ex-vivo genome-editing candidate, BEAM-101, in...
Beam Therapeutics Inc. BEAM is evaluating its leading ex-vivo genome-editing candidate, BEAM-101, in...